Search results
Molecular subgroups of T-cell acute lymphoblastic leukemia in adults treated according to...
Nature· 3 days agoIn contrast to B-cell precursor acute lymphoblastic leukemia (ALL), molecular subgroups are less well defined in T-lineage ALL. Comprehensive studies on ...
Study: Older Adults With Aggressive Blood Cancer A | Newswise
Newswise· 7 days agoStandard of care treatment for acute myeloid leukemia (AML) is safe and effective for adults over...
EHA 2024 | Results from Five Studies of Ascentage Pharma's Key Drug Candidates Selected for...
WRBL Columbus· 20 hours agoAscentage Pharma (6855.HK), a global biopharmaceutical company engaged in developing novel therapies for cancer, chronic hepatitis B (CHB), and age-related diseases, announced today that the ...
Small Business - Austin Daily Herald | Austin Daily Herald
Austin Daily Herald· 3 days agoAML is a cancer of the blood and bone marrow and is the most common type of acute leukemia in adults. SENTI-202, a potential first-in-class Logic Gated ...
Patients Over 80 Still Benefit From Treatment for AML Blood Cancer
Alaska Superstation· 2 days agoSeniors over 80 with acute myeloid leukemia can safely and effectively take the standard targeted...
Syndax Pharmaceuticals, Inc. (NASDAQ:SNDX) Q1 2024 Earnings Call Transcript
Insider Monkey via Yahoo Finance· 4 days agoSyndax Pharmaceuticals, Inc. (NASDAQ:SNDX) Q1 2024 Earnings Call Transcript May 8, 2024 Syndax...
Toddler, 2, dies months after his snoring was mistaken for a 'chesty cough'
The US Sun· 1 day agoThe concerned mum took him to the GP four times in three months but when Mason started vomiting,...
Danbury High runner who was on death bed with cancer graduates from Sacred Heart: 'Very determined'
The News-Times· 6 days agoIn May 2019, 21-year-old Alex Chakar was diagnosed with acute myeloid leukemia and within a few...
Sutro Biopharma shares hold on luvelta prospects By Investing.com
Investing.com· 2 days agoAdditionally, Sutro Biopharma...Biopharma plans to initiate the REFRaME-P1 pediatric study in the...
Celltrion USA's adalimumab-aaty biosimilar to HUMIRA® now available at low wholesale acquisition...
WTRF Wheeling· 7 days agoCelltrion USA announced today that adalimumab-aaty, the company's high-concentration (100 mg/mL) and citrate-free formulation biosimilar to HUMIRA ® (adalimumab), is now available at a low wholesale ...